Stanozolol 10mg BodyPharm

£38.00

Stanozolol 10mg BodyPharm tablets represent analytical-grade DHT derivatives designed for investigating androgenic anabolic pathways in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Stanozolol 10mg BodyPharm
Stanozolol 10mg BodyPharm
£38.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Stanozolol 10mg BodyPharm

Stanozolol 10mg BodyPharm is a synthetic dihydrotestosterone derivative formulated for comprehensive in-vitro research applications. This analytical compound enables researchers to investigate androgenic anabolic mechanisms, receptor binding affinities, and metabolic pathways within controlled laboratory settings. Each tablet contains precisely 10mg of stanozolol for consistent experimental protocols across multiple research studies.

Research scientists frequently examine stanozolol’s molecular interactions with androgen receptors, particularly its unique binding characteristics that differentiate it from testosterone-based compounds. The analytical-grade formulation ensures reproducible results when investigating protein synthesis pathways, nitrogen retention mechanisms, and cellular anabolic processes. Laboratories worldwide utilise this compound to study androgenic effects on muscle tissue cultures and examine its potential applications in regenerative medicine research.

Researchers at Stroid UK Shop appreciate the consistent quality standards maintained throughout BodyPharm’s manufacturing process, ensuring reliable experimental outcomes. The compound’s stability profile makes it particularly suitable for extended research protocols examining long-term cellular responses to androgenic stimulation.

Laboratory Research Applications

Stanozolol serves diverse research purposes across multiple scientific disciplines. Molecular biologists investigate its effects on gene expression patterns, particularly genes involved in protein synthesis and muscle development pathways. Biochemistry laboratories examine the compound’s metabolic transformation through cytochrome P450 enzymes, studying hepatic processing mechanisms and metabolite identification.

Endocrinology researchers evaluate stanozolol’s interactions with various hormone receptors, investigating its selectivity profiles compared to other androgenic compounds available through our oral steroids collection. Pharmacokinetic studies examine absorption rates, distribution patterns, and elimination pathways in laboratory models.

Cell culture studies utilise stanozolol to investigate myogenesis processes, examining how androgenic stimulation affects satellite cell activation and differentiation. Research teams also study the compound’s potential applications alongside other research chemicals from our SARMS range and peptides collection for comprehensive multi-pathway investigations.

Technical Specifications

Stanozolol 10mg BodyPharm Research Specifications
Parameter Specification
Active Compound Stanozolol
Concentration 10mg per tablet
CAS Number 10418-03-8
Molecular Formula C21H32N2O
Molecular Weight 328.49 g/mol
Storage Conditions Cool, dry place, protected from light
Manufacturer BodyPharm

Research Compliance Statement

Stanozolol 10mg BodyPharm tablets are manufactured exclusively for laboratory research purposes and in-vitro scientific investigations. This product is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. Researchers must ensure compliance with all applicable regulations governing analytical compound handling and disposal within their institutional frameworks.

Related